期刊文献+

吡柔比星及卡介苗膀胱灌注预防膀胱癌术后复发的临床观察 被引量:8

Observarion on the Effect of THP,BCG by Bladder Instillation to Prevent the Recurrence of the Bladder Cancer
下载PDF
导出
摘要 目的评价吡柔比星(THP)膀胱灌注及卡介苗(BCG)膀胱灌注预防膀胱癌术后复发的效果。方法患者随机分成两组,一组患者膀胱灌注THP(52例),另一组膀胱灌注卡介苗(47例),各组均灌注6~48个月,期间观察复发情况及不良反应。结果THP膀胱灌注组复发率为11.5%,无全身不良反应例子;卡介苗膀胱灌注组复发率为21.2%,68.1%患者出现膀胱刺激症状,两组比较THP组略好于。结论THP及卡介苗均是有效的预防膀胱癌术后复发的药物,THP膀胱灌注操作简单,全身不良反应小,是一种安全有效的膀胱局部化疗药物。 Objective To evaluate the effect of THP, BCG by bladder instillation to prevent the superficial bladder cancer recurrence, Methods 99 patients with superficial bladder cancer were divided into 2 groups randomly. THP by bladder instillation was used in the first group, BCG in the second group. They were all followed up 6 to 48 months. The recurrence and side effects were observed. Results The recurrence rate of bladder cancer in THP group was 11.5%. The recurrence rate in BCG group was 21.2%.The rate of side effect was 68.1%.The prevention of the THP group is better than the BCG group. Conclusion THP is an effective medicine to prevent the recurrence of the bladder cancer.
出处 《国际医药卫生导报》 2006年第8期67-68,共2页 International Medicine and Health Guidance News
关键词 膀胱肿瘤 吡柔比星 卡介苗 Bladder Cancer THP BCG
  • 相关文献

参考文献7

二级参考文献15

  • 1张广健,吴长利,韩瑞发,赵玉干,马腾骧,王广有,王凡.膀胱肿瘤抗药机制的实验研究[J].中华泌尿外科杂志,1996,17(4):203-206. 被引量:26
  • 2Lamm DL. Prophylaxis for recurrent transitional cell carcinoma[J].Urology, 1991,37(supp15) :21.
  • 3Lamm DL. Diagnosis and treatment at bladder cancer[J]. Anti-Drugs.1992, 3 (suppll) : 39-47.
  • 4Tachibana M, Jitsukaws S, Ligaya T, et al. Comparative study on prophylactic intravesical instillation of bacillus Calmettc-Guerin ( BCG )and adriamycin for superficial bladder cancers[ J ]. Nippon Hinyokika Gakkai Zasshi, 1989 Oct,80(10) : 1459-1465.
  • 5Nakagawa S, Kojima M ,Takada H, et al. Short duration bladder instillation therapy with pirarubiein for superficial bladder tumor based on pharmaeodynamie study [ J ]. Gan to Kagaku Rvoho 1992, 19 ( 11 ) :1873-1877.
  • 6Richie JP. Intravezical chemothetopy: Treatment selection, Techniques and Results[J]. U, C, N, A, 1992, 19( 3 ) : 523-524.
  • 7Kawamura S, Fujioka T, Kubo T, et al. A course of pirarubicin vesical irrigation at 30rag effectively prevents post-TUR recurrence of supedicial bladder cancer[ J ]. Jpn J cancer chemother, 1996,23 (4) : 465-470.
  • 8Kobayashi M,Sugaya Y.Yuzawa M,et al. Appropriate intravesical retention time of pirarubicin concertration based on its level in tumor tissue,anti-tumor effect and side effect in intravesical instillation therapy for bladder tumor [ J ]. Gan-To-Kagaku-Ryoho, 1988,15(11):1771-1774.
  • 9顾方六 吴阶平.尿路上皮肿瘤临床.泌尿外科[M].济南:山东科学技术出版社,1993.464.
  • 10吴阶平.泌尿外科学[M].济南:山东科学技术出版社,2003,4..

共引文献162

同被引文献79

引证文献8

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部